Red: This was not one of your better posts. Bad logic. Gerald's failure to address Jason's ridiculously low revenue figure cast a cloud over the stock preventing it from moving at all....even after we obtained orphan status on Retinitis and Launched Lympro, two massive catalysts!!

Clearly someone as smart as you sees that Jason's low estimate combined with Gerald's failure to address it put a lid on the stock price these past two months? If Gerald had given us real revenue guidance as he promised he would, and if it approached 20 million, we would be trading much higher than .08 cents right now!